The global generic sterile injectables market in 2020 is estimated for more than US$ 434.7 Bn and expected to reach a value of US$ 930.3 Bn by 2028 with a significant CAGR of 10.0%.
According to the latest report by IMARC Group, titled “Latin America Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” The Latin America generic injectables market is expected to...
In 2020, global multiple sclerosis treatment market was valued at US$ 23.6 Bn and expected to grow significantly at a CAGR of 5.7% over the forecast period